Brain cancer vaccine (Northwest Biotherapeutics)

N/A

Report date: 2024/07/03 21:31:43

Base Information

Drug NameBrain cancer vaccine (Northwest Biotherapeutics)

Drug Alias Name脑肿瘤疫苗 - Northwest BiotherapeuticsDCVax-BrainDendritic cell immunotherapy (brain cancer)Dendritic cell-based immunotherapy (brain cancer)DCVax-Brain personalised immune therapy +[9]

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsBrain NeoplasmsGlioblastomaGlioma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanadaUnited StatesGermany +[4]

CombinationsNo

Global Highest StatusPending (Phase 3 Clinical)

Highest Status in ChinaN/A

Originator CompaniesNorthwest Biotherapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNorthwest Biotherapeutics Inc

Active IndicationsN/A

Inactive IndicationsBrain NeoplasmsGlioblastomaGlioma

Other Information

ATC CodeN/A